Product Information
TRI-LO-MILI TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1049 per EA under NDC 65862077828. Its NADAC has been published 193 times since Oct 19, 2022.
Manufacturer
Aurobindo Pharma LimitedNDC
65862077828
Classification
Generic
Dosage Form
KIT
Last Updated
6/17/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA205762On Market Since
11/4/2016
Price Statistics
The NADAC for TRI-LO-MILI TABLET has been published 193 times since Oct 19, 2022, and over the history we have for it it has declined 35.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1049 per EA |
|---|---|
| All-time high | $0.1726 (Dec 14, 2022) |
| All-time low | $0.0903 (Nov 20, 2024) |
| 52-week high | $0.1162 |
| 52-week low | $0.1049 |
| Median price | $0.1162 |
| Average price | $0.1258 |
| Largest weekly change | -27.8% (Apr 17, 2024) |
| Weeks tracked | 193 |
| Tracking since | Oct 19, 2022 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TRI-LO-MILI TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TRI-LO-MILI TABLET, manufactured by Aurobindo Pharma Limited, is $0.1049 per EA (NDC 65862077828), effective Jun 24, 2026.
How has the price of TRI-LO-MILI TABLET changed over time?
Over the history we have for it, the NADAC for TRI-LO-MILI TABLET has declined 35.8%. It has been tracked across 193 weekly CMS publications since Oct 19, 2022.
What are the highest and lowest recorded NADAC prices for TRI-LO-MILI TABLET?
Since Oct 19, 2022, the NADAC for TRI-LO-MILI TABLET has ranged from a low of $0.0903 (Nov 20, 2024) to a high of $0.1726 (Dec 14, 2022), with a median of $0.1162 per EA.
Are there cheaper alternatives to TRI-LO-MILI TABLET?
7 NADAC-published products share the same active ingredient, strength, and dosage form as TRI-LO-MILI TABLET, but none are currently priced below it.
Who manufactures TRI-LO-MILI TABLET?
TRI-LO-MILI TABLET (NDC 65862077828) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification